Monte Rosa Therapeutics, Inc. (GLUE)
23.99
+0.27
(+1.14%)
USD |
NASDAQ |
Jan 13, 16:00
24.00
+0.01
(+0.04%)
After-Hours: 20:00
Monte Rosa Therapeutics Market Cap: 1.562B for Jan. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.418B |
| CorMedix, Inc. | 556.25M |
| Indivior PLC | 4.251B |
| Mirum Pharmaceuticals, Inc. | 4.648B |
| Innovative Eyewear, Inc. | 8.988M |
Market Cap Related Metrics
| PE Ratio | 78.55 |
| PS Ratio | 10.21 |
| Price to Book Value | 6.354 |
| Price to Free Cash Flow | 12.78 |
| Price | 23.99 |
| Earnings Yield | 1.27% |
| Operating PE Ratio | 217.78 |
| Normalized PE Ratio | 78.55 |